A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.
Clinical trial NCT00261430 · COMPLETED
Trial details
- NCT number
- NCT00261430
- Sponsor
- Janssen, LP
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Enrollment
- 650
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.